// COMPANY
General Bio
SECTOR BIOTECHMENTIONS 1LAST SEEN JULY 20, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Lucinda Shen·JULY 20, 2026
“General Bio, an SF-based developer of oral GLP-1s and other peptides, raised $7.4M seed.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.